A proposal to make it easier for generic drug companies to copy brand-name medicines for sale to impoverished countries will be debated by a House of Commons committee.
A private member's bill to reform Canada's Access to Medicines Regime was passed by Commons on second reading last night.
The existing legislation, which was introduced by a Liberal government five years ago to facilitate the flow of cheap generic drugs to the Third World, has been so fraught with problems that it has been almost unworkable.